141 related articles for article (PubMed ID: 25541413)
1. Allosteric activation of the 5-HT3AB receptor by mCPBG.
Miles TF; Lester HA; Dougherty DA
Neuropharmacology; 2015 Apr; 91():103-8. PubMed ID: 25541413
[TBL] [Abstract][Full Text] [Related]
2. Importance of recognition loops B and D in the activation of human 5-HT₃ receptors by 5-HT and meta-chlorophenylbiguanide.
Michaelson SD; Paulsen IM; Kozuska JL; Martin IL; Dunn SM
Neuropharmacology; 2013 Oct; 73():398-403. PubMed ID: 23810831
[TBL] [Abstract][Full Text] [Related]
3. Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor.
Lochner M; Lummis SC
Biophys J; 2010 Apr; 98(8):1494-502. PubMed ID: 20409468
[TBL] [Abstract][Full Text] [Related]
4. A single channel mutation alters agonist efficacy at 5-HT3A and 5-HT3AB receptors.
Thompson AJ; Lummis SC
Br J Pharmacol; 2013 Sep; 170(2):391-402. PubMed ID: 23822584
[TBL] [Abstract][Full Text] [Related]
5. The loop C region of the murine 5-HT3A receptor contributes to the differential actions of 5-hydroxytryptamine and m-chlorophenylbiguanide.
Suryanarayanan A; Joshi PR; Bikádi Z; Mani M; Kulkarni TR; Gaines C; Schulte MK
Biochemistry; 2005 Jun; 44(25):9140-9. PubMed ID: 15966738
[TBL] [Abstract][Full Text] [Related]
6. Different efficacy of specific agonists at 5-HT3 receptor splice variants: the role of the extra six amino acid segment.
Niemeyer MI; Lummis SC
Br J Pharmacol; 1998 Feb; 123(4):661-6. PubMed ID: 9517385
[TBL] [Abstract][Full Text] [Related]
7. Subtle Differences among 5-HT
Price KL; Hirayama Y; Lummis SCR
ACS Chem Neurosci; 2017 May; 8(5):1085-1091. PubMed ID: 28367632
[TBL] [Abstract][Full Text] [Related]
8. Discriminating between 5-HT₃A and 5-HT₃AB receptors.
Thompson AJ; Lummis SC
Br J Pharmacol; 2013 Jun; 169(4):736-47. PubMed ID: 23489111
[TBL] [Abstract][Full Text] [Related]
9. 5-HT(3) receptors.
Lummis SC
J Biol Chem; 2012 Nov; 287(48):40239-45. PubMed ID: 23038271
[TBL] [Abstract][Full Text] [Related]
10. 5-Chloroindole: a potent allosteric modulator of the 5-HT₃ receptor.
Newman AS; Batis N; Grafton G; Caputo F; Brady CA; Lambert JJ; Peters JA; Gordon J; Brain KL; Powell AD; Barnes NM
Br J Pharmacol; 2013 Jul; 169(6):1228-38. PubMed ID: 23594147
[TBL] [Abstract][Full Text] [Related]
11. A coupled array of noncovalent interactions impacts the function of the 5-HT3A serotonin receptor in an agonist-specific way.
Miles TF; Bower KS; Lester HA; Dougherty DA
ACS Chem Neurosci; 2012 Oct; 3(10):753-60. PubMed ID: 23077719
[TBL] [Abstract][Full Text] [Related]
12. Identification of a domain affecting agonist potency of meta-chlorophenylbiguanide in 5-HT3 receptors.
Mochizuki S; Miyake A; Furuichi K
Eur J Pharmacol; 1999 Mar; 369(1):125-32. PubMed ID: 10204690
[TBL] [Abstract][Full Text] [Related]
13. Activation of 5-HT3 receptors leads to altered responses 6 months after MDMA treatment.
Gyongyosi N; Balogh B; Katai Z; Molnar E; Laufer R; Tekes K; Bagdy G
J Neural Transm (Vienna); 2010 Mar; 117(3):285-92. PubMed ID: 20052506
[TBL] [Abstract][Full Text] [Related]
14. Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT3 receptors.
Moura Barbosa AJ; De Rienzo F; Ramos MJ; Menziani MC
Eur J Med Chem; 2010 Nov; 45(11):4746-60. PubMed ID: 20724042
[TBL] [Abstract][Full Text] [Related]
15. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
[TBL] [Abstract][Full Text] [Related]
16. The binding characteristics and orientation of a novel radioligand with distinct properties at 5-HT3A and 5-HT3AB receptors.
Thompson AJ; Verheij MH; Verbeek J; Windhorst AD; de Esch IJ; Lummis SC
Neuropharmacology; 2014 Nov; 86():378-88. PubMed ID: 25174552
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of ligand recognition in 5-HT3 receptors.
Kesters D; Thompson AJ; Brams M; van Elk R; Spurny R; Geitmann M; Villalgordo JM; Guskov A; Danielson UH; Lummis SC; Smit AB; Ulens C
EMBO Rep; 2013 Jan; 14(1):49-56. PubMed ID: 23196367
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of quinoxaline-based 5-HT3A and 5-HT3AB receptor-selective ligands.
Thompson AJ; Verheij MH; van Muijlwijk-Koezen JE; Lummis SC; Leurs R; de Esch IJ
ChemMedChem; 2013 Jun; 8(6):946-55. PubMed ID: 23640722
[TBL] [Abstract][Full Text] [Related]
19. A first step towards the understanding of the 5-HT3 receptor subunit heterogeneity from a computational point of view.
De Rienzo F; Del Cadia M; Menziani MC
Phys Chem Chem Phys; 2012 Sep; 14(36):12625-36. PubMed ID: 22880201
[TBL] [Abstract][Full Text] [Related]
20. 5-HT3 receptors.
Thompson AJ; Lummis SC
Curr Pharm Des; 2006; 12(28):3615-30. PubMed ID: 17073663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
